Aeglea BioTherapeutics
Drugs for the treatment of tumors the company was incorporated in 2013 and is based in texas.
Launch date
Employees
Market cap
AUD2.3b
Enterprise valuation
AUD1.8b (Public information from Sep 2024)
Share price
$30.4 AGLE
Austin Texas (HQ)
Authorizing premium user...